Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy

Clinical trial NCT01085058 · COMPLETED

Trial details

NCT number: NCT01085058
Sponsor: WiSP Wissenschaftlicher Service Pharma GmbH
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hodgkin's Disease Non-Hodgkin Lymphomas Multiple Myelomas

Start date: 2003-05-01
Primary completion: 2004-12-01
Enrollment: 169

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.